SAM
EWTX icon

Smartleaf Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Smartleaf Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.63K Hold
162
– – ﹤0.01% 2566
2026
Q1 		$4.91K Sell
162
-11
-6% -$317 ﹤0.01% 2665
2025
Q4 		$4.25K Buy
173
+146
+541% +$2.93K ﹤0.01% 2768
2025
Q3 		$425 Buy
27
+1
+4% +$14 ﹤0.01% 2878
2025
Q2 		$342 Buy
26
+5
+24% +$72 ﹤0.01% 2627
2025
Q1 		$488 Hold
21
– – ﹤0.01% 2702
2024
Q4 		$568 Sell
21
-55
-72% -$1.75K ﹤0.01% 2767
2024
Q3 		$1.98K Hold
76
– – ﹤0.01% 2476
2024
Q2 		$1.33K Buy
+76
New +$1.33K ﹤0.01% 2348

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Smartleaf Asset Management's EWTX Position: Q2 2026 in Review

Smartleaf Asset Management held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 162 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

Smartleaf Asset Management first reported a position in EWTX in Q2 2024 and has held it in 9 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Smartleaf Asset Management held 162 shares of Edgewise Therapeutics worth $6.63K as of Q2 2026.
  • Smartleaf Asset Management left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2566 holding.
  • Smartleaf Asset Management first reported a position in Edgewise Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.